Automated Methods for the Analysis of Skeletal Muscle Fiber Size and Metabolic Type - International Review of Cell and Molecular Biology - page 314

Andersen, P., Henriksson, J., 1977. Capillary supply of the quadriceps femoris muscle of man:
adaptive response to exercise. J. Physiol. 270, 677-690.
Apostolova, N., Blas-Garcia, A., Esplugues, J.V., 2011.Mitochondrial interference by anti-HIV
drugs: mechanisms beyond Pol-gamma inhibition. Trends Pharmacol. Sci. 32, 715-725.
Argiles, J.M., Lopez-Soriano, F.J., Busquets, S., 2007. Mechanisms to explain wasting of
muscle and fat in cancer cachexia. Curr. Opin. Support. Palliat. Care 1, 293-298.
Aspnes, L.E., Lee, C.M., Weindruch, R., Chung, S.S., Roecker, E.B., Aiken, J.M., 1997.
Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle.
FASEB J. 11, 573-581.
Aure, K., Fayet, G., Leroy, J.P., Lacene, E., Romero, N.B., Lombes, A., 2006. Apoptosis in
mitochondrial myopathies is linked to mitochondrial proliferation. Brain 129,

1249-1259.
Bajusz, E., 1964. “Red” skeletal muscle fibers: relative independence of neural control. Sci-
ence 145, 938-939.
Barron, M.J., Chinnery, P.F., Howel, D., Blakely, E.L., Schaefer, A.M., Taylor, R.W.,
Turnbull, D.M., 2005. Cytochrome c oxidase deficient muscle fibres: substantial varia-
tion in their proportions within skeletal muscles from patients with mitochondrial myop-
athy. Neuromuscul. Disord. 15, 768-774.
Basaria, S., 2010. Androgen abuse in athletes: detection and consequences. J. Clin.

Endocrinol. Metab. 95, 1533-1543.
Bauman, W.A., Adkins, R.H., Spungen, A.M., Waters, R.L., 1999. The effect of residual
neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury.
Spinal Cord 37, 765-771.
Bell, C.D., Conen, P.E., 1967. Change in fiber size in Duchenne muscular dystrophy. Neu-
rology 17, 902-913.
Berdeaux, R., Stewart, R., 2012. cAMP signaling in skeletal muscle adaptation: hypertrophy,
metabolism, and regeneration. Am. J. Physiol. Endocrinol. Metab. 303, E1-E17.
Berglund, L., Bjorling, E., Oksvold, P., Fagerberg, L., Asplund, A., Szigyarto, C.A.,
Persson, A., Ottosson, J., Wernerus, H., Nilsson, P., Lundberg, E., Sivertsson, A.,
Navani, S., Wester, K., Kampf, C., Hober, S., Ponten, F., Uhlen, M., 2008.
A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol.
Cell. Proteomics 7, 2019-2027.
Bertini, E., D'Amico, A., Gualandi, F., Petrini, S., 2011. Congenital muscular dystrophies: a
brief review. Semin. Pediatr. Neurol. 18, 277-288.
Bidlingmaier, M., Strasburger, C.J., 2010. Growth hormone. Handb. Exp. Pharmacol. 195,
187-200.
Biering-Sorensen, B., Kristensen, I.B., Kjaer, M., Biering-Sorensen, F., 2009. Muscle after
spinal cord injury. Muscle Nerve 40, 499-519.
Blanco, C.E., Sieck, G.C., Edgerton, V.R., 1988. Quantitative histochemical determination
of succinic dehydrogenase activity in skeletal muscle fibres. Histochem. J. 20, 230-243.
Blanco, C.E., Micevych, P.E., Zhan, W.Z., Sieck, G.C., 1995. Succinate dehydrogenase
activity of sexually dimorphic muscles of rats. J. Appl. Physiol. 78, 2147-2152.
Bloemberg, D., Quadrilatero, J., 2012. Rapid determination of myosin heavy chain expres-
sion in rat, mouse, and human skeletal muscle using multicolor immunofluorescence
analysis. PLoS One 7, e35273.
Bodine, S.C., Stitt, T.N., Gonzalez, M., Kline, W.O., Stover, G.L., Bauerlein, R.,
Zlotchenko, E., Scrimgeour, A., Lawrence, J.C., Glass, D.J., Yancopoulos, G.D.,
2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and
can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014-1019.
Bowerman, M., Beauvais, A., Anderson, C.L., Kothary, R., 2010. Rho-kinase inactivation
prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet. 19,
1468-1478.